Imlygic
talimogene laherparepvec
- Strength
- 1000000 [PFU]/mL
- Form
- Injection, Suspension
Amgen Inc
Not stocked by us — reference only
talimogene laherparepvec
Listed by Amgen Inc
| Dosage form | Injection, Suspension |
|---|---|
| Route | Intralesional |
| Approval route | BLA — biologic licence |
| NDC code | 55513-079 |
| FDA application | BLA125518 |
| RxNorm concept | 1721278 |
| Package sizes listed | 1 |
| Marketed since | November 2015 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
talimogene laherparepvec
Amgen Inc
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.